Gastrointestinal symptoms and psychological well-being in patients with microscopic colitis

References

• Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 2001;36:545–52.
   PubMed Web of Science ®Google Scholar
• Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002;97:389–96.
   PubMed Web of Science ®Google Scholar
• Hjortswang H, Tysk C, Bohr J, Benoni C, Vigren L, Kilander A, Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis 2011;43:102–9.
   PubMedGoogle Scholar
• Chande N, Driman DK, Reynolds RP. Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scand J Gastroenterol 2005;40:343–7.
   PubMed Web of Science ®Google Scholar
• Talley NJ. Irritable bowel syndrome. Intern Med J 2006;36:724–8.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Corrazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG, Rome 3rd: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates; 2006.
   Google Scholar
• Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology 2011;140:1155–65.
   PubMed Web of Science ®Google Scholar
• Lazenby AJ. Collagenous and lymphocytic colitis. Semin Diagn Pathol 2005;22:295–300.
   PubMed Web of Science ®Google Scholar
• Fernández-Bañares F. How much symptom overlap is there between microscopic colitis and IBS? Nat Clin Pract Gastroenterol Hepatol 2007;4:304–5.
   PubMedGoogle Scholar
• Limsui D, Pardi DS, Camilleri M, Loftus EV Jr, Kammer PP, Tremaine WJ, Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175–81.
   PubMed Web of Science ®Google Scholar
• Ohlsson B, Sjoberg K, Alm R, Fredrikson GN. Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum. Neurogastroenterol Motil 2011;23:1000–6.
   PubMed Web of Science ®Google Scholar
• Reinhart GJ, Xie Q, Liu XJ, Zhu YF, Fan J, Chen C, Species selectivity of nonpeptide antagonists of the gonadotropin-releasing hormone receptor is determined by residues in extracellular loops II and III and the amino terminus. J Biol Chem 2004;279:34115–22.
   PubMed Web of Science ®Google Scholar
• Svedlund J, Sjödin I, Dotevall G. GSRS – a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129–34.
   PubMed Web of Science ®Google Scholar
• Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms An improved evaluation of treatment regimens? Scand J Gastroenterol 1993;28:681–7.
   PubMedGoogle Scholar
• Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046–52.
   PubMed Web of Science ®Google Scholar
• Dupy H. The psychological general well-being (PGWB) index. In Wenger NK, Mattson ME, Furberg CF, Elinson J, editors. Assessment of quality of life in clinical trails of cardiovascular therapies. New York: Le Jacq Publishing; 1984.
   Google Scholar
• Bengtsson M, Ohlsson B, Ulander K. Development and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS). BMC Gastroenterol 2007;7:16.
   PubMed Web of Science ®Google Scholar
• Ozdil K, Sahin A, Calhan T, Kahraman R, Nigdelioglu A, Akyuz The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome. BMC Gastroenterol 2011;11:96.
   PubMed Web of Science ®Google Scholar
• Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804–11.
   PubMed Web of Science ®Google Scholar
• O´Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449–57.
   PubMedGoogle Scholar
• Wood J. Functional abdominal pain: the basic science. J Pediatr Gastroenterol Nutr 2008;47:688–93.
   PubMedGoogle Scholar
• Dorn SD, Palsson OS, Thiwan SI, Kanazawa M, Clark WC, van Tilburg MA, Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007;56:1202–9.
   PubMed Web of Science ®Google Scholar
• Nozu T, Kudaira M. Altered rectal sensory response induced by balloon distention in patients with functional abdominal pain syndrome. Biopsychosoc Med 2009;3:13.
   PubMedGoogle Scholar
• Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol 2011;11:122.
   PubMed Web of Science ®Google Scholar
• Huang W, Yao B, Sun L, Pu R, Wang L, Zhang R. Immunohistochemical and in situ hybridization studies of gonadotropin releasing hormone (GnRH) and its receptor in rat digestive tract. Life Sci 2001;68:1727–34.
   PubMed Web of Science ®Google Scholar
• Soldani G, Del Tacca M, Bambini G, Polloni A, Bernardini C, Martinotti E, Effects of gonadotropin-releasing hormone (GnRH) on gastric secretion and gastrin release in the dog. J Endocrinol Invest 1982;5:393–6.
   PubMedGoogle Scholar
• Khanna R, Browne RM, Heiner AD, Clench MH, Mathias JR. Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy. Am J Physiol 1992;262:G185–90.
   PubMedGoogle Scholar
• Darro F, Camby I, Kruczynski A, Pasteels JL, Martinez J, Kiss R. Characterisation of the influence of anti-gastrin, anti-epidermal growth factor, anti-oestradiol, and anti-luteinising hormone releasing hormone antibodies on the proliferation of 27 cell lines from the gastrointestinal tract. Gut 1995;36:220–30.
   PubMedGoogle Scholar
• Rabin D, McNeil LW. Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females. J Clin Endocrinol Metab 1980;51:873–6.
   PubMed Web of Science ®Google Scholar
• Ducker TE, Boss JW, Altug SA, Mehrabian H, Dekeratry DR, Clench MH, Luteinizing hormone and human chorionic gonadotropin fragment the migrating myoelectric complex in rat small intestine. Neurogastroenterol Motil 1996;8:95–100.
   PubMed Web of Science ®Google Scholar
• Wang F, Zheng TZ, Li W, Qu SY, He DY. Action of progesterone on contractile activity of isolated gastric strips in rats. World J Gastroenterol 2003;9:775–8.
   PubMedGoogle Scholar
• Mathias JR, Clench MH, Reeves-Darby VG, Fox LM, Hsu PH, Roberts PH, Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci 1994;39:1155–62.
   PubMed Web of Science ®Google Scholar
• Hammar O, Veress B, Montgomery A, Ohlsson B. Expression of luteinizing hormone receptor in the gastrointestinal tract in patients with and without dysmotility. Drug Target Insights 2012;6:13–18.
   PubMedGoogle Scholar
• Fromme B, Eftekhari P, Regenmortel MV, Hoebeke J, Katz A, Millar R. A novel retro-inverso gonadotropin-releasing hormone (GnRH) immunogen elicits antibodies that neutralize the activity of native GnRH. Endocrinology 2003;144:3262–9.
   PubMed Web of Science ®Google Scholar
• Delogu LG, Deidda S, Delitala G, Manetti R. Infectious diseases and autoimmunity. J Infect Dev Ctries 2011;5:679–87.
   PubMed Web of Science ®Google Scholar